Brian Duffy joins SurgaColl as Operations Director

We are very pleased to announce the appointment of Brian Duffy as Operations Director, reporting directly to Bill Allan, CEO. Brian has great experience in the medical industry and has worked for Abbott, Medtronic and Boston Scientific in senior operational roles and has led significant projects. Brian is an ASQ certified Six Sigma black belt […]

Read the latest blog from Biotech and Money

Biotech and Money is the influential community of senior life science decision makers and the Drugs & Dealers Blog provides genuine thought leadership, exclusive executive insight and market intelligence on the life science and healthcare investment sector. Click here to read the latest blog reporting on Surgacoll’s £3.1M Series A investment to drive next phase […]

Dr Paul Bielderman joins SurgaColl as Medical Director

We are very pleased to announce the appointment of Dr Paul Bielderman as Medical Director reporting directly to the CEO. Paul has a long heritage as a physician in the medical industry and has worked in both devices and pharma in a range of Medical Affairs and Medical Director roles, including Covidien (now Medtronic), Kyphon […]

SurgaColl Holdings formed and Series A Funding round completed

SurgaColl technologies Ltd has completed a  corporate restructuring and established a UK based holding company, SurgaColl Holdings Ltd and closed a £3.1m funding round led by Catapult Ventures (see detail below). The funds will be used to continue clinical evidence development, product development and building a world class team. Click here to read the full […]

John Hoare joins SurgaColl as QA/RA Manager and member of Leadership Team

We are very pleased to announce the appointment of John Hoare as QA/RA Manager for SurgaColl Ltd reporting directly to the CEO. John has strong experience in both Quality Affairs and Regulatory Affairs, in the Medical Device and Pharma sectors and joins us from Bausch and Lomb. He has had US and Canada based experience […]

European Grant (Horizon 2020) awarded to SurgaColl

SurgaColl technologies has been awarded a European Grant (Horizon 2020) as part of a consortium of organisations working towards ‘Controlling Cartilage to Bone Transitions for improved Treatment of Bone defects and Osteoarthritis’. The consortium  is led by Erasmus University in Rotterdam and includes IRCCS in Genoa, Trinity College Dublin, Klinikum der Universität zu Köln, Royal Veterinary College, […]

the MedTech Strategist

We are excited to be involved at the forthcoming MedTech Strategist Innovation Summit in Dublin 25-27 April at the Shelbourne Hotel, Dublin, Ireland. We are delighted and privileged to have a presentation slot on Day 1 and would welcome you to come and listen to our CEO, Bill Allan. For more information, please click here […]

No bones about it, Surgacoll plans to create 25 jobs by 2019

Surgacoll, which has created a bone regeneration product from technology developed at the Royal College of Surgeons in Ireland (RCSI), has received the CE mark, certifying it for sale throughout the EU and plans to create 25 new jobs in the next three years. Surgacoll Technologies, a high potential start-up (HPSU) supported by Enterprise Ireland, intends […]

Technology Showcase in Westport, Ireland

SurgaColl were invited to present their exciting ChondroColl technology at the Technology Showcase event organised as part of the Mayo Arthroscopy Conference in Westport on Friday evening 24th February. The Mayo Arthroplasty Conference is the largest joint replacement conference on the island of Ireland. The conference is an annual event and is now in its […]

Medtech and Money event

Our CEO Bill Allan and Dr John Gleeson, CTO were excited to attend the 3rd Annual Conference Medtech and Money on 7-8 February in London. Bill presented to an audience of almost 550 delegates on day 2. The 3rd Annual Conference continued a relentless focus on quality peer-2-peer discussion, high level networking and partnering, unique […]